Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Journal of Neurology|July 9, 2025
Familial myasthenia gravis: characterization of an Israeli cohort and systematic review of the literatureMark A Hellmann, Israel Steiner, Maor Mermelstein, et al.
Acta Neurologica Scandinavica|March 8, 2020
Incidence of AChR Ab-positive myasthenia gravis in Israel: A population-based studyItay Lotan, Felix Benninger, Mark A Hellmann, et al.
Transplantation Proceedings|July 31, 2018
Ureteric Stenting in Kidney Transplant Recipients, Gdansk Centre Experience, PolandB Bzoma, J Kostro, A Hellmann, et al.
Cells|April 13, 2019
Characterization of Brassica rapa RAP2.4-Related Proteins in Stress Response and as CUL3-Dependent E3 Ligase SubstratesSutton Mooney, Raed Al-Saharin, Christina M Choi, et al.
Neuromuscular Disorders : NMD|March 1, 2022
Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravisItay Lotan, Mark A Hellmann, Yitzhak Friedman, et al.
Leukemia|December 13, 2003
Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III studyM Michallet, F Maloisel, M Delain, et al.
Polskie Archiwum Medycyny Wewnetrznej|April 4, 2002
[Evaluation of blood morphology in patients with refractory multiple myeloma treated with thalidomide]N Grzaśko, A Dmoszyńska, S Krawczyk, et al.
European Journal of Nuclear Medicine|September 1, 1993
Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomographyC Guertner, H Klepzig, F D Maul, et al.
European Journal of Neurology|July 21, 2021
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in IsraelItay Lotan, Adi Wilf-Yarkoni, Yitzhak Friedman, et al.
Annals of Hematology|November 1, 1996
Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patientsM Griesshammer, B Heinze, A Hellmann, et al.
Pageof 18